Dr. Alireza Khadem is a pharmacist by background with extensive experience in pharmaceutical and biopharmaceutical production, quality control, quality assurance, and regulatory affairs. He began his career at the Pasteur Institute of Iran in 1997. In 2008, he joined the World Health Organization (WHO) Regional Office for South-East Asia (SEARO), and in 2010, he moved to the WHO Headquarters to work on the Regulatory System Strengthening (RSS) Program. In his role within the RSS team, Dr. Khadem focuses on supporting WHO member states in strengthening their national regulatory capacity to ensure access to safe, effective, and high-quality medical products. Throughout his career at the WHO, he has played a key role in developing WHO guidelines, policies, methodologies, and benchmarking tools for regulatory systems and has led numerous national regulatory authority (NRA) benchmarking activities. He has contributed to several significant initiatives, including the development of the WHO Good Regulatory Practices (GRP) guidelines, the Coalition of Interested Partners (CIP), and the WHO Listed Authority (WLA). Currently, he leads the Regulatory Systems Strengthening (RSS) team within the Regulation and Safety Unit.
